Bio-Europe, Hamburg, Germany, November 11-13, 2019.

Xplico will be present at BIO-Europe 2019 in Hamburg, Germany on November 11^th to 13^th. BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. In addition to productive partnering, BIO-Europe offers high level workshops, panels, company presentations, and a lively exhibition. Please contact us to book a meeting, either during the conference or at a time convenient for you, to discuss how you can benefit from our valuation services.

(August 2019)

BioFIT, Marseille, France, December 10-11, 2019.

Please meet us at the BioFIT conference in Marseille, France, in December 2019. BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. (August 2019)

Biotech Showcase, San Fransisco, USA, January 13-15, 2020.

Please meet us at the 2020 Biotech Showcase in San Francisco. The investor and networking conference for public and private biotech companies to meet with and present to investors and pharmaceutical executives during the course of the healthcare industry's most important week of the year.

(October 2019)

LSX World Conference, London, United Kingdom, February 4-5, 2020.

Xplico will be present at the LSX World Congress in London on February 4^th and 5^th 2020. The LSX World Congress brings together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal making and commercialization – from the founders and CEOs of innovative start-ups to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

(October 2019)

Bio Europe Spring, Paris, March 23-25, 2020.

Please meet us at the 2020 Bio Europe Spring Partnering Conference in Paris, France from March 23^rd to 25^th. With a focus on European innovation and global collaboration, BIO-Europe Spring is the largest springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in the most innovative biopharma clusters in Europe.

(October 2019)

BIO Convention, San Diego, USA, June 8-11, 2020.

Join us at the BIO International Convention in San Diego in June 2020 and Go BEYOND. This year the Convention reflects on the passion, drive and risk-taking of an industry that consistently strives to accomplish things that others might deem impossible—an industry that goes BEYOND. The key benefits of attending the Convention are access to global biotech and pharma leaders via partnering and unparalleled networking opportunities with 17,000+ attendees.

(October 2019)

Xplico elected a Gazelle Company for the 4th year in a row

We are proud to announce that Xplico has been elected a Gazelle company for the 4^th year in a row.

The election is organized by the Danish financial newspaper Børsen, and the requirements to become a Gazelle company are tough. A Gazelle business is continuously growing and, as a minimum, doubles its revenue or gross profit over four fiscal years, while maintaining positive growth throughout the years.

It is quite impressive that we have been able to live up to this four years in a row and we express our gratitude to our customers because without their continuous support and trust this would not have been possible.

The new Xplico Evaluator template is now released

Xplico proudly releases a new and enhanced version of Xplico Evaluator, our valuation tool, available for all our subscription customers.

Many things have been changed behind the scene, with only a few changes in the way the assumptions are entered. The new version can handle more advanced Deal Terms and it has more features as well as additional outputs.

(June 2019)

Publication of the Xplico Valuation Survey

(November 2018)

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Finn Nikolajsen, gives his point of view on the challenges of the ownership structures that the biotech companies and their investors face when they try to analyze the consequences of current and future funding rounds and exits.

Read the full article

(October 2018)

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

Read the full article

(August 2018)

Xplico Interview with Biotech & Money / LSX

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the common pitfalls companies encounter when using valuation models that are built in house.

Read the interview

(June 2018)